Seeking Alpha

Acorda Therapeutics (ACOR): Q4 EPS of $0.40 may not be comparable to consensus of $0.24. Revenue...

Acorda Therapeutics (ACOR): Q4 EPS of $0.40 may not be comparable to consensus of $0.24. Revenue of $72.6M (+7.2% Y/Y) beats by $3.5M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector